Aktis Oncology, Inc. (AKTS)

18.58 -0.40 (-2.11%) USD  |  NASDAQ  |  Jun 10, 16:00
18.84 +0.26 (+1.40%) After-Hours: 05:03
More

Aktis Oncology Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for AKTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Return on Net Operating Assets Data

View and export this data back to 2026. Start Trial.
Date Value
March 31, 2026 --

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
MetaVia, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade